Skip to Main Content

Paper Details

Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101).
Clin Cancer Res
6
2023
Cancer, GIST, Patients, Sarcoma, advanced sarcoma, gastrointestinal stromal tumor, leiomyosarcoma, liposarcoma, metastatic sarcoma, patients, sarcoma, tumors
Author NameAffiliation
Jordi RodonDepartment of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center
Shubham PantDepartment of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center
Alexander J LazarThe University of Texas MD Anderson Cancer Center
Najat C DawThe University of Texas MD Anderson Cancer Center
Joseph A LudwigThe University of Texas MD Anderson Cancer Center
Richard GorlickThe University of Texas MD Anderson Cancer Center
Richard GorlickThe University of Texas MD Anderson Cancer Center
Richard GorlickThe University of Texas MD Anderson Cancer Center
Richard GorlickThe University of Texas MD Anderson Cancer Center
Funda Meric-BernstamDepartment of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center
  • 1 - 10

Datasets

Release 1.2